Glenmede Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Sell |
167,483
-6,923
| -4% | -$571K | 0.07% | 259 |
|
|
2025
Q4 | $14.9M | Buy |
+174,406
| New | +$14.3M | 0.07% | 238 |
|
|
2025
Q1 | $16.1M | Sell |
222,551
-126,499
| -36% | -$9.05M | 0.09% | 222 |
|
|
2024
Q4 | $25.8M | Sell |
349,050
-32,118
| -8% | -$2.25M | 0.13% | 143 |
|
|
2024
Q3 | $25.2M | Buy |
381,168
+21,505
| +6% | +$1.56M | 0.12% | 167 |
|
|
2024
Q2 | $33.2M | Sell |
359,663
-883
| -0.2% | -$78.2K | 0.17% | 118 |
|
|
2024
Q1 | $34.5M | Buy |
360,546
+1,194
| +0.3% | +$100K | 0.17% | 126 |
|
|
2023
Q4 | $27.4M | Sell |
359,352
-1,338
| -0.4% | -$93.1K | 0.14% | 150 |
|
|
2023
Q3 | $25M | Sell |
360,690
-797
| -0.2% | -$64K | 0.14% | 154 |
|
|
2023
Q2 | $29.9M | Hold |
361,487
| – | – | 0.17% | 135 |
|
|
2023
Q1 | $29.9M | Sell |
361,487
-7,638
| -2% | -$600K | 0.17% | 135 |
|
|
2022
Q4 | $27.5M | Sell |
369,125
-133,351
| -27% | -$10.3M | 0.16% | 147 |
|
|
2022
Q3 | $41.5M | Buy |
502,476
+3,229
| +0.6% | +$311K | 0.26% | 101 |
|
|
2022
Q2 | $47.5M | Buy |
499,247
+132,316
| +36% | +$13.7M | 0.28% | 91 |
|
|
2022
Q1 | $43.2M | Sell |
366,931
-731
| -0.2% | -$82K | 0.21% | 116 |
|
|
2021
Q4 | $47.6M | Sell |
367,662
-919
| -0.2% | -$107K | 0.23% | 108 |
|
|
2021
Q3 | $41.7M | Sell |
368,581
-9,651
| -3% | -$1.1M | 0.22% | 115 |
|
|
2021
Q2 | $39.2M | Sell |
378,232
-9,244
| -2% | -$871K | 0.2% | 125 |
|
|
2021
Q1 | $32.4M | Sell |
387,476
-2,607
| -0.7% | -$220K | 0.17% | 142 |
|
|
2020
Q4 | $35.6M | Sell |
390,083
-2,019
| -0.5% | -$167K | 0.2% | 123 |
|
|
2020
Q3 | $31.3M | Buy |
392,102
+2,359
| +0.6% | +$184K | 0.19% | 134 |
|
|
2020
Q2 | $26.9M | Sell |
389,743
-7,922
| -2% | -$563K | 0.16% | 141 |
|
|
2020
Q1 | $30.9M | Hold |
397,665
| – | – | 0.14% | 199 |
|
|
2019
Q4 | $30.9M | Buy |
397,665
+14,331
| +4% | +$1.12M | 0.14% | 199 |
|
|
2019
Q3 | $28.1K | Sell |
383,334
-55,092
| -13% | -$3.87M | 0.13% | 217 |
|
|
2019
Q2 | $27K | Buy |
438,426
+11,358
| +3% | +$687K | 0.12% | 249 |
|
|
2019
Q1 | $27.2K | Sell |
427,068
-918,174
| -68% | -$52.4M | 0.12% | 252 |
|
|
2018
Q4 | $68.7K | Buy |
1,345,242
+904,491
| +205% | +$45.8M | 0.34% | 73 |
|
|
2018
Q3 | $25.6M | Sell |
440,751
-12,126
| -3% | -$593K | 0.1% | 286 |
|
|
2018
Q2 | $22M | Buy |
452,877
+22,446
| +5% | +$1.05M | 0.1% | 287 |
|
|
2018
Q1 | $16.2M | Hold |
430,431
| – | – | 0.07% | 325 |
|
|
2017
Q4 | $16.2M | Buy |
430,431
+1,845
| +0.4% | +$67.7K | 0.07% | 325 |
|
|
2017
Q3 | $15.6M | Buy |
428,586
+120
| +0% | +$4.58K | 0.07% | 324 |
|
|
2017
Q2 | $13.4M | Hold |
428,466
| – | – | 0.06% | 332 |
|
|
2017
Q1 | $13.4M | Buy |
428,466
+21,282
| +5% | +$666K | 0.06% | 332 |
|
|
2016
Q4 | $12.7M | Buy |
407,184
+338,820
| +496% | +$11M | 0.07% | 337 |
|
|
2016
Q3 | $2.75M | Sell |
68,364
-17,481
| -20% | -$658K | 0.02% | 563 |
|
|
2016
Q2 | $2.85M | Buy |
85,845
+15,828
| +23% | +$542K | 0.02% | 547 |
|
|
2016
Q1 | $2.06M | Sell |
70,017
-229,146
| -77% | -$6.32M | 0.01% | 608 |
|
|
2015
Q4 | $7.87M | Sell |
299,163
-551,079
| -65% | -$14.3M | 0.05% | 362 |
|
|
2015
Q3 | $20.1M | Sell |
850,242
-123,984
| -13% | -$2.99M | 0.15% | 236 |
|
|
2015
Q2 | $23.1M | Sell |
974,226
-363,702
| -27% | -$8.21M | 0.17% | 209 |
|
|
2015
Q1 | $31.8M | Buy |
1,337,928
+489,270
| +58% | +$11M | 0.23% | 122 |
|
|
2014
Q4 | $18M | Buy |
848,658
+44,916
| +6% | +$902K | 0.14% | 229 |
|
|
2014
Q3 | $13.7M | Buy |
803,742
+790,842
| +6,131% | +$12.5M | 0.12% | 252 |
|
|
2014
Q2 | $184K | Hold |
12,900
| – | – | ﹤0.01% | 1201 |
|
|
2014
Q1 | $159K | Hold |
12,900
| – | – | ﹤0.01% | 1254 |
|
|
2013
Q4 | $140K | Sell |
12,900
-84
| -0.6% | -$947 | ﹤0.01% | 1273 |
|
|
2013
Q3 | $150K | Buy |
12,984
+84
| +0.7% | +$983 | ﹤0.01% | 1236 |
|
|
2013
Q2 | $143K | Buy |
+12,900
| New | +$153K | ﹤0.01% | 1200 |
|
Other funds holding EW
VCM
VPM
Glenmede Trust's EW Position: Q1 2026 in Review
Glenmede Trust reduced its Edwards Lifesciences (EW) stake by 4% in Q1 2026, selling an estimated $571K and leaving 167,483 shares worth $13.4M. The position accounts for 0.07% of the portfolio, ranked #259.
Glenmede Trust first reported a position in EW in Q2 2013 and has held it in 50 quarters since. The position peaked at $47.6M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Glenmede Trust held 167,483 shares of Edwards Lifesciences worth $13.4M as of Q1 2026.
- Glenmede Trust sold 6,923 Edwards Lifesciences shares in Q1 2026, an estimated $571K.
- Edwards Lifesciences made up 0.07% of Glenmede Trust's portfolio in Q1 2026, its #259 holding.
- Glenmede Trust first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's Edwards Lifesciences position peaked at $47.6M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.